Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Introduction: The severe condition develops in every fifth patient with coronavirus disease 2019 (COVID-19). This study is aimed to assess the factors predicting severe and critical conditions in hypertensive patients with COVID-19-associated pneumonia. Materials and methods: A total of 106 unvaccinated hypertensive patients hospitalized for COVID-19-associated pneumonia were enrolled in the study. Results: Median body mass index (BMI) was higher in patients with severe/critical condition [30.4 (26.4–34.1) kg/m2] than in patients with moderate condition [25.3 (23.5–29.1) kg/m2] (p < 0.001). Diabetes mellitus was more prevalent in patients with severe/critical condition (40.7 vs 21.3%, p = 0.04). Erythrocyte sedimentation rate (ESR) was higher in patients with severe/critical condition [28.0 (14.0–34.5) vs 37.5 (24.0–46.5) mm/hour] (0.004). Patients who developed severe/critical condition were scored higher according to the community-acquired pneumonia symptom (CAP-Sym) questionnaire [30.0 (20.0–37.0) points] than patients who developed the moderate condition [22.0 (16.0–33.0) points] (p = 0.03). Also, ferritin level was higher in patients who developed severe/critical condition [430.5 (177.0–733.0) ng/mL] than in patients who developed the moderate condition [315.5 (169.0–396.0) ng/mL] (p = 0.03). BMI of ≥30 kg/m2 increased the odds of severe/critical condition development [odds ratio (OR) = 3.83 (1.61–9.09), p = 0.002] and was the only independent predictor for the severe/critical condition according to the multivariate logistic regression analysis. Conclusion: Increased BMI, diabetes mellitus, high ESR, and ferritin level at admission predict severe/critical disease in unvaccinated hypertensive patients hospitalized for COVID-19. However, only BMI of ≥30 kg/m2 is an independent risk factor for severe/critical disease according to multivariate logistic regression analysis. CAP-Sym questionnaire may be used for the prediction of severe/critical COVID-19.
Introduction: The severe condition develops in every fifth patient with coronavirus disease 2019 (COVID-19). This study is aimed to assess the factors predicting severe and critical conditions in hypertensive patients with COVID-19-associated pneumonia. Materials and methods: A total of 106 unvaccinated hypertensive patients hospitalized for COVID-19-associated pneumonia were enrolled in the study. Results: Median body mass index (BMI) was higher in patients with severe/critical condition [30.4 (26.4–34.1) kg/m2] than in patients with moderate condition [25.3 (23.5–29.1) kg/m2] (p < 0.001). Diabetes mellitus was more prevalent in patients with severe/critical condition (40.7 vs 21.3%, p = 0.04). Erythrocyte sedimentation rate (ESR) was higher in patients with severe/critical condition [28.0 (14.0–34.5) vs 37.5 (24.0–46.5) mm/hour] (0.004). Patients who developed severe/critical condition were scored higher according to the community-acquired pneumonia symptom (CAP-Sym) questionnaire [30.0 (20.0–37.0) points] than patients who developed the moderate condition [22.0 (16.0–33.0) points] (p = 0.03). Also, ferritin level was higher in patients who developed severe/critical condition [430.5 (177.0–733.0) ng/mL] than in patients who developed the moderate condition [315.5 (169.0–396.0) ng/mL] (p = 0.03). BMI of ≥30 kg/m2 increased the odds of severe/critical condition development [odds ratio (OR) = 3.83 (1.61–9.09), p = 0.002] and was the only independent predictor for the severe/critical condition according to the multivariate logistic regression analysis. Conclusion: Increased BMI, diabetes mellitus, high ESR, and ferritin level at admission predict severe/critical disease in unvaccinated hypertensive patients hospitalized for COVID-19. However, only BMI of ≥30 kg/m2 is an independent risk factor for severe/critical disease according to multivariate logistic regression analysis. CAP-Sym questionnaire may be used for the prediction of severe/critical COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.